Related references
Note: Only part of the references are listed.PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
Tamara L. Lotan et al.
MODERN PATHOLOGY (2015)
PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy
Gloria Irene Manfredi et al.
ENDOCRINE (2015)
PTEN Mutations and Activation of the PI3K/Akt/mTOR Signaling Pathway in Papillary Tumors of the Pineal Region
Tobias Goschzik et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2014)
Upregulation of the PI3K/Akt Pathway in the Tumorigenesis of Canine Thyroid Carcinoma
M. Campos et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2014)
PTEN C-Terminal Deletion Causes Genomic Instability and Tumor Development
Zhuo Sun et al.
CELL REPORTS (2014)
Methylation analysis of the phosphates and tensin homologue on chromosome 10 gene (PTEN) in multiple myeloma
Giovanna Piras et al.
CLINICAL EPIGENETICS (2014)
Targeting PI3K/Akt/mTOR signaling in cancer
Camillo Porta et al.
FRONTIERS IN ONCOLOGY (2014)
Correlation of Immunohistochemical Markers and BRAF Mutation Status with Histological Variants of Papillary Thyroid Carcinoma in the Korean Population
Hye Sook Min et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2013)
VIEWPOINT Increasing incidence of thyroid cancer: controversies explored
Yasuhiro Ito et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Follicular Variant of Papillary Thyroid Carcinoma is a Unique Clinical Entity: A Population-Based Study of 10,740 Cases
Xiao-Min Yu et al.
THYROID (2013)
Reduced expression of PTEN and increased PTEN phosphorylation at residue Ser380 in gastric cancer tissues: A novel mechanism of PTEN inactivation
Zhen Yang et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2013)
Changing trends in well differentiated thyroid carcinoma over eight decades
Iain J. Nixon et al.
INTERNATIONAL JOURNAL OF SURGERY (2012)
New Targeted Therapies for Thyroid Cancer
Alessandro Antonelli et al.
CURRENT GENOMICS (2011)
Thyroid Incidentaloma Detected by Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Practical Management Algorithm
Inga-Lena Nilsson et al.
WORLD JOURNAL OF SURGERY (2011)
Mutational and Immunohistochemical Study of the PI3K/Akt Pathway in Papillary Thyroid Carcinoma in Greece
Elias Sozopoulos et al.
ENDOCRINE PATHOLOGY (2010)
Visually Discernible [18F]Fluorodeoxyglucose Uptake in Papillary Thyroid Microcarcinoma: A Potential New Risk Factor
Mijin Yun et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Association of PTEN Gene Methylation With Genetic Alterations in the Phosphatidylinositol 3-Kinase/AKT Signaling Pathway in Thyroid Tumors
Peng Hou et al.
CANCER (2008)
Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers
Zhi Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The PTEN-PI3K pathway: of feedbacks and cross-talks
A. Carracedo et al.
ONCOGENE (2008)
Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists
A. Salajegheh et al.
POSTGRADUATE MEDICAL JOURNAL (2008)
Follicular variant of papillary thyroid carcinoma: Clinical-pathological characterization and long-term follow-up
Philippe Hagag et al.
CANCER JOURNAL (2006)
Increasing incidence of thyroid cancer in the United States, 1973-2002
L Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
PTEN promoter methylation in sporadic thyroid carcinomas
F Alvarez-Nunez et al.
THYROID (2006)
Tumor suppressor gene allelic loss profiles of the variants of papillary thyroid carcinoma
JL Hunt et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2004)
Pure versus follicular variant of papillary thyroid carcinoma - Clinical features, prognostic factors, treatment, and survival
J Zidan et al.
CANCER (2003)
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
F Chang et al.
LEUKEMIA (2003)
The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus - Implications for PTEN stability to proteasome-mediated degradation
J Torres et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Phosphorylation of the PTEN tail regulates protein stability and function
F Vazquez et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
PTEN expression is reduced in a subset of sporadic thyroid carcinomas:: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1
P Bruni et al.
ONCOGENE (2000)
Share Paper
